One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Immunotherapy for Sarcoma: A Work in Progress.
Meyer, Christian F. MD, PhD 1,,
doi : 10.1200/JCO.21.01338
Volume 40(12) pgs. 1267-1392 April 20, 2022
Durvalumab Induces Sustained Survival Benefit After Concurrent Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Pujol, Jean-Louis MD, PhD 1,,
doi : 10.1200/JCO.22.00204
Therapy for Muscle-Invasive Urothelial Carcinoma: Controversies and Dilemmas.
Sonpavde, Guru P. MD 1,,; Mouw, Kent W. MD, PhD 2,; Mossanen, Matthew MD, MPH 3,
doi : 10.1200/JCO.21.02928
Risk of COVID-19 Infections and of Severe Complications Among Survivors of Childhood, Adolescent, and Young Adult Cancer: A Population-Based Study in Ontario, Canada.
Gupta, Sumit MD, PhD 1,2,3,4,,; Sutradhar, Rinku PhD 3,4; Alexander, Sarah MD 1; Science, Michelle MD 2,5; Lau, Cindy MPH 3; Nagamuthu, Chenthila MPH 3; Agha, Mohammad PhD 6,7,8; Nathan, Paul C. MD 1,2,3,4; Hodgson, David MD 7,9
doi : 10.1200/JCO.21.02592
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1.
Chawla, Sant P. MD 1,; Van Tine, Brian A. MD, PhD 2,; Pollack, Seth M. MD 3,4,; Ganjoo, Kristen N. MD 5,; Elias, Anthony D. MD 6,; Riedel, Richard F. MD 7,; Attia, Steven DO 8,; Choy, Edwin MD, PhD 9,; Okuno, Scott H. MD 10; Agulnik, Mark MD 11,12,; von Mehren, Margaret MD 13,; Livingston, Michael B. MD 14; Keedy, Vicki L. MD 15,; Verschraegen, Claire F. MD 16; Philip, Tony MD 17,; Bohac, G. Chet MD 18,19,; Yurasov, Sergey MD, PhD 18,20,; Yakovich, Adam PhD 18,21,; Lu, Hailing MD, PhD 18,22,; Chen, Michael MSc 18,23,; Maki, Robert G. MD, PhD 24,,
doi : 10.1200/JCO.20.03452
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Spigel, David R. MD 1,,; Faivre-Finn, Corinne MD, PhD 2,; Gray, Jhanelle E. MD 3,; Vicente, David MD 4,; Planchard, David MD, PhD 5,; Paz-Ares, Luis MD, PhD 6; Vansteenkiste, Johan F. MD, PhD 7,; Garassino, Marina C. MD 8,9,; Hui, Rina PhD 10,; Quantin, Xavier MD, PhD 11,; Rimner, Andreas MD 12,; Wu, Yi-Long MD 13,; Ozguroglu, Mustafa MD 14,; Lee, Ki H. MD 15,; Kato, Terufumi MD 16,; de Wit, Maike MD, PhD 17,; Kurata, Takayasu MD 18,; Reck, Martin MD, PhD 19,; Cho, Byoung C. MD, PhD 20,; Senan, Suresh PhD 21,; Naidoo, Jarushka MBBCH, MHS 22,; Mann, Helen MSc 23,; Newton, Michael PharmD 24,; Thiyagarajah, Piruntha MD 23,; Antonia, Scott J. MD, PhD 3,
doi : 10.1200/JCO.21.01308
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
Funt, Samuel A. MD 1,2,,; Lattanzi, Michael MD 1; Whiting, Karissa MS 1; Al-Ahmadie, Hikmat MD 1,; Quinlan, Colleen BA 1; Teo, Min Yuen MD 1,2,; Lee, Chung-Han MD 1,2,; Aggen, David MD 1,2,; Zimmerman, Danielle MD 1,2; McHugh, Deaglan MD 1,2,; Apollo, Arlyn MD 1,2,; Durdin, Trey D. MD 1; Truong, Hong MD 1; Kamradt, Jeffrey MD 3; Khalil, Maged MD 4; Lash, Bradley MD 4; Ostrovnaya, Irina PhD 1; McCoy, Asia S. RN BSN 1; Hettich, Grace RN BSN 1; Regazzi, Ashley BS 1; Jihad, Marwah MS 1; Ratna, Neha BA 1; Boswell, Abigail BA 1; Francese, Kaitlyn MSN 5,; Yang, Yuanquan MD 6,; Folefac, Edmund MD 6; Herr, Harry W. MD 1; Donat, S. Machele MD 1; Pietzak, Eugene MD 1,; Cha, Eugene K. MD 1; Donahue, Timothy F. MD 1; Goh, Alvin C. MD 1,; Huang, William C. MD 5,; Bajorin, Dean F. MD 1,2,; Iyer, Gopa MD 1,2,; Bochner, Bernard H. MD 1,; Balar, Arjun V. MD 5,; Mortazavi, Amir MD 6,; Rosenberg, Jonathan E. MD 1,2,
doi : 10.1200/JCO.21.01485
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.
Shepherd, Jonathan H. PhD 1; Ballman, Karla PhD 2,; Polley, Mei-Yin C. PhD 3; Campbell, Jordan D. PhD 2; Fan, Cheng MS 1; Selitsky, Sara PhD 4,; Fernandez-Martinez, Aranzazu MD 1; Parker, Joel S. PhD 5,; Hoadley, Katherine A. PhD 1,6; Hu, Zhiyuan PhD 1; Li, Yan PhD 1; Soloway, Matthew G. MS 1; Spears, Patricia A. MS 1,; Singh, Baljit MD 7; Tolaney, Sara M. MD, MPH 8,; Somlo, George MD 9; Port, Elisa R. MD 10; Ma, Cynthia MD, PhD 11,; Kuzma, Charles MD 12; Mamounas, Eleftherios MD, MPH 13,; Golshan, Mehra MD 14,; Bellon, Jennifer R. MD 8,; Collyar, Deborah BS 15,; Hahn, Olwen M. MD 16,; Hudis, Clifford A. MD 17,; Winer, Eric P. MD 8,; Partridge, Ann MD 8,; Hyslop, Terry PhD 18,; Carey, Lisa A. MD 19,; Perou, Charles M. PhD 1,6,; Sikov, William M. MD 20,,
doi : 10.1200/JCO.21.01506
Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.
Lopes Cardozo, Josephine M.N. MD 1,2; Drukker, Caroline A. MD, PhD 1; Rutgers, Emiel J.T. MD, PhD 1,; Schmidt, Marjanka K. PhD 3; Glas, Annuska M. PhD 4,; Witteveen, Anke BSc 4,; Cardoso, Fatima MD 5,; Piccart, Martine MD, PhD 6,; Esserman, Laura J. MD, MBA 7,; Poncet, Coralie MSc 2; van 't Veer, Laura J. PhD 8,,
doi : 10.1200/JCO.21.02019
First Extensive Analysis of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Large Cohort of Patients With HIV-Associated Hodgkin Lymphoma: Baseline Total Metabolic Tumor Volume Affects Prognosis.
Louarn, Nicolas MD, MSc 1,2,3; Galicier, Lionel MD 4,5,; Bertinchamp, Remi MD 4; Lussato, David MD 6; Montravers, Francoise MD, PhD 7,8; Oksenhendler, Eric MD 4,9,; Merlet, Pascal MD, PhD 1,9; Gerard, Laurence MD 4; Vercellino, Laetitia MD, PhD 1,10,
doi : 10.1200/JCO.21.01228
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
Daly, Megan E. MD 1,; Singh, Navneet MD, DM 2; Ismaila, Nofisat MD, MSc 3,; Antonoff, Mara B. MD 4; Arenberg, Douglas A. MD 5,; Bradley, Jeffrey MD 6,; David, Elizabeth MD 7,; Detterbeck, Frank MD 8; Fruh, Martin MD 9,10,; Gubens, Matthew A. MD, MS 11,; Moore, Amy C. PhD 12,; Padda, Sukhmani K. MD 13,; Patel, Jyoti D. MD 14,; Phillips, Tanyanika MD, MPH 15,; Qin, Angel MD 5,; Robinson, Clifford MD 16,; Simone, Charles B. II MD 17,
doi : 10.1200/JCO.21.02528
Treatment of Low Sexual Desire in Female Cancer Survivors.
Bluming, Avrum Z. MD, MACP; Tavris, Carol A. PhD
doi : 10.1200/JCO.22.00067
The Last Dance for Chemotherapy Intensification in Non-Asian Advanced Biliary Tract Cancers?.
Salati, Massimiliano MD; Rizzo, Alessandro MD
doi : 10.1200/JCO.21.02509
